Brimonidine/Timolol Fixed Combination Prophylaxis for Intraocular Pressure Elevation Following Intravitreal Injection of Antivascular Endothelial Growth Factor

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 24 May 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

19 May 2023 Status changed from not yet recruiting to withdrawn prior to enrolment.
17 Aug 2018 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.
17 Aug 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com